Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Inoperable Locally Advanced HER2-Negative Breast Cancer × eribulin × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Neoplasm Metastasis 1 Liposarcoma 1 HR+HER2- Breast Cancer 1 Carcinoma, Transitional Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡